- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06727526
Acupressure's Impact on Pain and Physiological Parameters in Infants Undergoing Cardiac Catheterization
December 13, 2024 updated by: Ilcim Ercan Koyuncu, Baskent University
The Effect of Acupressure on Pain and Physiological Parameters in Infants Before and After Cardiac Catheterization: a Randomized Placebo Controlled Trial
Acupressure, one of the traditional Chinese medicine practices dating back approximately 5,000 years, is a mind-body technique that can be independently applied by nurses.
This practice involves applying pressure to specific points on the body to reduce pain.
The pressure stimulates the release of substances such as endorphins, acetylcholine, norepinephrine, and dopamine, resulting in muscle relaxation, regulated blood circulation, and blocked pain signals at nerve endings, effectively reducing the sensation of pain.
The aim of acupressure is to alleviate patient discomfort and improve quality of life by reducing the need for analgesics.
Acupressure, which falls under the category of therapeutic massage, can be applied using the fingers and palms.
According to its core philosophy, illness arises when the balance of energy flowing through body channels, called "meridians," is disrupted.
Because acupressure does not involve needles, it is a safe, effective, and economical technique that is easy to learn and apply.
The World Health Organization (WHO) classifies acupressure as a supportive treatment within its list of "treatable conditions."
The technique involves applying pressure to the same point for 2-5 minutes.
Stimulating specific points promotes the release of cytokines, such as endorphins, which play a role in pain reduction by blocking certain receptors on sensory nerve endings and thus preventing pain perception.
Additionally, stimulating acupoints helps establish sympathetic and parasympathetic balance, supporting healthy homeostasis.
Studies in the literature have investigated acupressure's positive effects on children's preoperative anxiety, postoperative pain severity, chemotherapy side effects, fatigue, sleep quality, asthma symptoms, and physical stress.
In a study examining the impact of acupressure on procedural pain in infants prior to parenteral vaccinations, infants who received acupressure experienced lower pain levels and shorter crying durations.
Similarly, a study investigating the effect of acupressure on acute pain during venous catheter insertion in children found that pain severity was lower among children who received acupressure.
A systematic review examining the effects of acupressure on child health determined that acupressure is effective in alleviating procedural pain in children.
The review emphasized that nurses should incorporate acupressure, a non-pharmacological method, into care practices for effective pain management in children.
Despite evidence in the literature supporting acupressure's positive effects on pediatric health, no study has specifically examined its impact on pain and physiological parameters in children undergoing cardiac catheterization.
Therefore, this thesis aims to investigate the effects of acupressure, applied before and after cardiac catheterization, on pain levels and physiological parameters in infants.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: İlçim Ercan
- Phone Number: 05534700629
- Email: ilcimercan@hotmail.com
Study Contact Backup
- Name: Duygu Gözen, Prof. Dr.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Infants between 1 month and 12 months
- Infants with congenital heart disease
- Infants undergoing cardiac catheterization for the first time
- Infants undergoing planned cardiac catheterization
- Infants without acupressure experience
- Infants whose parents volunteered to participate in the study
Exclusion Criteria:
- Infants with complications during catheterization
- Infants followed up in the intensive care unit after catheterization
- Infants with any deformity or lesion in the acupressure area
- Infants who have not received analgesics after catheterization
- Infants who were not given analgesics within six hours before catheterization
- Infants with neurodevelopmental disorders
- Infants whose parents did not volunteer to participate in the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acupressure Group
Infants in this group will undergo acupressure both before and after cardiac catheterization.
The initial session will be administered by the researcher 30 minutes prior to the procedure.
Acupressure will target three specific points: the seventh point of the heart meridian (HT7), the fourth point of the large intestine meridian (LI4), and the sixth point of the pericardial meridian (PC6).
The areas will be warmed for approximately 20 seconds to minimize tissue sensitivity, avoiding direct pressure on the acupressure points.
Each point will receive 12 minutes of treatment, comprising 10 seconds of compression followed by 2 seconds of relaxation, applied symmetrically.
After this initial session, the infant will undergo cardiac catheterization.
Upon return to the ward post-catheterization, a second acupressure session will be conducted one hour after the administration of the final dose of ketamine hydrochloride.
|
The literature found that acupressure positively affects child health, but no study was found to determine the effect of acupressure on pain and physiological parameters in children undergoing cardiac catheterization.
Therefore, this study was designed to determine the effect of acupressure applied before and after cardiac catheterization on infants' pain levels and physiological parameters.
|
|
Placebo Comparator: Plasebo
Infants in this group will receive placebo acupressure before and after cardiac catheterization.
The initial session will be administered 30 minutes before the procedure, targeting areas approximately 1-1.5 cm away from HT7, LI4, and PC6 points, where meridians do not pass.
The areas will be warmed for 20 seconds to minimize tissue sensitivity, avoiding direct pressure on acupressure points.
Each site will receive 12 minutes of treatment, alternating 10 seconds of compression and 2 seconds of relaxation, applied symmetrically.
Post-catheterization, a second placebo session will be conducted an hour after the last dose of ketamine hydrochloride.
|
In health sciences, placebo refers to an inactive intervention used to relax the patient and assess treatment efficacy.
It may involve inert substances (e.g., sugar tablets, saline) or non-therapeutic interventions (e.g., artificial electrical stimulation or conversations).
Expectancy theory often explains The placebo effect, which suggests that treatment expectations can induce physiological changes.
Factors like age, cognitive development, and previous pain experiences influence children's responses to placebo.
Parental belief in an intervention's efficacy can reduce a child's pain expectations and positively influence their perception of pain.
Although the sample included young children, our study incorporated the placebo group to account for this effect, especially since the parents evaluated pain scores.
|
|
No Intervention: Control Group
Infants in this group will not receive any specific intervention and will be provided routine care in the ward.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pain
Time Frame: 30 minutes after the first procedure, 30 minutes after the second procedure, 2 hours after the second procedure, 24 hours after the second procedure
|
The Face, Legs, Activity, Cry, Consolability (FLACC) scale will assess the pain.
The FLACC scale is a measurement used to assess pain for children between the ages of 1 month and 7 years or individuals who are unable to communicate their pain.
The scale is scored in a range of 0-10, with 0 representing no pain.
As the score increases, the patient's pain increases.
|
30 minutes after the first procedure, 30 minutes after the second procedure, 2 hours after the second procedure, 24 hours after the second procedure
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Heart Rate
Time Frame: 30 minutes after the first procedure, 30 minutes after the second procedure, 2 hours after the second procedure, 24 hours after the second procedure
|
Maintaining or normalizing heart rate within normal range (100-160)
|
30 minutes after the first procedure, 30 minutes after the second procedure, 2 hours after the second procedure, 24 hours after the second procedure
|
|
Saturation
Time Frame: 30 minutes after the first procedure, 30 minutes after the second procedure, 2 hours after the second procedure, 24 hours after the second procedure
|
Normalizing or maintaining saturation rate within the normal range according to the child.
|
30 minutes after the first procedure, 30 minutes after the second procedure, 2 hours after the second procedure, 24 hours after the second procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Bastani F, Khosravi M, Borimnejad L, Arbabi N. The effect of acupressure on cancer-related fatigue among school-aged children with acute lymphoblastic leukemia. Iran J Nurs Midwifery Res. 2015 Sep-Oct;20(5):545-51. doi: 10.4103/1735-9066.164508.
- Alakhfash AA, Jelly A, Almesned A, Alqwaiee A, Almutairi M, Salah S, Hasan M, Almuhaya M, Alnajjar A, Mofeed M, Nasser B. Cardiac Catheterisation Interventions in Neonates and Infants Less Than Three Months. J Saudi Heart Assoc. 2020 May 12;32(2):149-156. doi: 10.37616/2212-5043.1051. eCollection 2020.
- Koc Ozkan T, Balci S. The Effect of Acupressure on Acute Pain During Venipuncture in Children: Implications for Evidence-Based Practice. Worldviews Evid Based Nurs. 2020 Jun;17(3):221-228. doi: 10.1111/wvn.12437. Epub 2020 Apr 22.
- American Academy of Pediatrics, Committee on Pediatric Emergency Medicine; American College of Emergency Physicians, Pediatric Committee; Emergency Nurses Association, Pediatric Committee. Joint policy statement--guidelines for care of children in the emergency department. J Emerg Nurs. 2013 Mar;39(2):116-31. doi: 10.1016/j.jen.2013.01.003.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
December 30, 2024
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 30, 2025
Study Registration Dates
First Submitted
December 9, 2024
First Submitted That Met QC Criteria
December 9, 2024
First Posted (Actual)
December 11, 2024
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
December 13, 2024
Last Verified
December 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- Acupressure in Infants
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.